|  Help  |  About  |  Contact Us

Publication : In vivo detection of amyloid β deposition using ¹⁹F magnetic resonance imaging with a ¹⁹F-containing curcumin derivative in a mouse model of Alzheimer's disease.

First Author  Yanagisawa D Year  2011
Journal  Neuroscience Volume  184
Pages  120-7 PubMed ID  21497641
Mgi Jnum  J:173944 Mgi Id  MGI:5050583
Doi  10.1016/j.neuroscience.2011.03.071 Citation  Yanagisawa D, et al. (2011) In vivo detection of amyloid beta deposition using (1)(9)F magnetic resonance imaging with a (1)(9)F-containing curcumin derivative in a mouse model of Alzheimer's disease. Neuroscience 184:120-7
abstractText  Amyloid beta (Abeta) deposition in the brain is considered the initiating event in the progression of Alzheimer''s disease (AD). Amyloid imaging is widely studied in diagnosing AD and evaluating the disease stage, with considerable advances achieved in recent years. We have developed a novel (1)F-containing curcumin derivative (named FMeC1) as a potential imaging agent. This compound can exist in equilibrium between keto and enol tautomers, with the enol form able to bind Abeta aggregates while the keto form cannot. This study investigated whether FMeC1 is suitable as a (1)F magnetic resonance imaging (MRI) probe to detect Abeta deposition in the Tg2576 mouse, a model of AD. In (1)F nuclear magnetic resonance (NMR) spectra obtained from the whole head, a delayed decreased rate of F (1)F signal was observed in Tg2576 mice that were peripherally injected with FMeC1 in comparison to wild-type mice. Furthermore, (1)F MRI displayed remarkable levels of (1)F signal in the brain of Tg2576 mice after the injection of FMeC1. Histological analysis of FMeC1-injected mouse brain showed penetration of the compound across the blood-brain barrier and binding to Abeta plaques in peripherally injected Tg2576 mice. Moreover, the distribution of Abeta deposits in Tg2576 mice was in accordance with the region of the brain in which the (1)F signal was imaged. FMeC1 also exhibited an affinity for senile plaques in human brain sections. These findings suggest the usefulness of FMeC1 as a (1)F MRI probe for the detection of amyloid deposition in the brain. Furthermore, the properties of FMeC1 could form the basis for further novel amyloid imaging probes.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression